Ying Liu1, Shu Jiang1, Peng-Yuan Yang2, Yue-Fan Zhang3, Tie-Jun Li1, Yao-Cheng Rui4. 1. Department of Pharmacology, College of Pharmacy, Second Military Medical University, Shanghai, China. 2. CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China. 3. Department of Pharmacology, College of Pharmacy, Second Military Medical University, Shanghai, China. ruiyc163@163.com. 4. Department of Pharmacology, College of Pharmacy, Second Military Medical University, Shanghai, China. zhangyuefan@126.com.
Abstract
AIMS: In our previous study, eEF1A1 was identified to be a new target for protecting brain ischemia injury, but the mechanism remains largely unknown. In this study, we screened the downstream cellular protein molecules interacted with eEF1A1 and found mechanism of eEF1A1 in brain ischemia protection. METHODS AND RESULTS: Through co-immunoprecipitation and mass spectrometry for searching the interaction of proteins with eEF1A1 in bEnd3 cells, HSC70 was identified to be a binding protein of eEF1A1, which was further validated by Western blot and immunofluorescence. eEF1A1 or HSC70 knockdown, respectively, increased OGD-induced apoptosis of brain vascular endothelial cells, which was detected by Annexin V-FITC/PI staining. HSC70 or eEF1A1 knockdown enhances phosphorylated JNK, phosphorylation of c-JUN (Ser63, Ser73), cleaved caspase-9, and cleaved caspase-3 expression, which could be rescued by JNK inhibitor. CONCLUSION: In summary, our data suggest that the presence of chaperone forms of interaction between eEF1A1 and HSC70 in brain vascular endothelial cells, eEF1A1 and HSC70 can play a protective role in the process of ischemic stroke by inhibiting the JNK signaling pathway activation.
AIMS: In our previous study, eEF1A1 was identified to be a new target for protecting brain ischemia injury, but the mechanism remains largely unknown. In this study, we screened the downstream cellular protein molecules interacted with eEF1A1 and found mechanism of eEF1A1 in brain ischemia protection. METHODS AND RESULTS: Through co-immunoprecipitation and mass spectrometry for searching the interaction of proteins with eEF1A1 in bEnd3 cells, HSC70 was identified to be a binding protein of eEF1A1, which was further validated by Western blot and immunofluorescence. eEF1A1 or HSC70 knockdown, respectively, increased OGD-induced apoptosis of brain vascular endothelial cells, which was detected by Annexin V-FITC/PI staining. HSC70 or eEF1A1 knockdown enhances phosphorylated JNK, phosphorylation of c-JUN (Ser63, Ser73), cleaved caspase-9, and cleaved caspase-3 expression, which could be rescued by JNK inhibitor. CONCLUSION: In summary, our data suggest that the presence of chaperone forms of interaction between eEF1A1 and HSC70 in brain vascular endothelial cells, eEF1A1 and HSC70 can play a protective role in the process of ischemic stroke by inhibiting the JNK signaling pathway activation.
Authors: Sabine Westphal; Christian Stoppe; Matthias Gruenewald; Berthold Bein; Jochen Renner; Jochen Cremer; Mark Coburn; Gereon Schaelte; Andreas Boening; Bernd Niemann; Frank Kletzin; Jan Roesner; Ulrich Strouhal; Christian Reyher; Rita Laufenberg-Feldmann; Marion Ferner; Ivo F Brandes; Martin Bauer; Andreas Kortgen; Sebastian N Stehr; Maria Wittmann; Georg Baumgarten; Rafael Struck; Tanja Meyer-Treschan; Peter Kienbaum; Matthias Heringlake; Julika Schoen; Michael Sander; Sascha Treskatsch; Thorsten Smul; Ewa Wolwender; Thomas Schilling; Frauke Degenhardt; Andre Franke; Soeren Mucha; Lukas Tittmann; Madeline Kohlhaas; Georg Fuernau; Oana Brosteanu; Dirk Hasenclever; Kai Zacharowski; Patrick Meybohm Journal: BMC Cardiovasc Disord Date: 2019-01-24 Impact factor: 2.298
Authors: Bożena Gabryel; Klaudia Bontor; Karolina Jarząbek; Marta Plato; Anna Pudełko; Grzegorz Machnik; Tomasz Urbanek Journal: Arch Med Sci Date: 2019-02-11 Impact factor: 3.318
Authors: Aleksandra Turek-Jakubowska; Janusz Dębski; Maciej Jakubowski; Ewa Szahidewicz-Krupska; Jakub Gawryś; Karolina Gawryś; Agnieszka Janus; Małgorzata Trocha; Adrian Doroszko Journal: J Clin Med Date: 2022-01-11 Impact factor: 4.241